ATE413889T1 - Insulin angereichertes säuglingsnährpräparat - Google Patents
Insulin angereichertes säuglingsnährpräparatInfo
- Publication number
- ATE413889T1 ATE413889T1 AT99927267T AT99927267T ATE413889T1 AT E413889 T1 ATE413889 T1 AT E413889T1 AT 99927267 T AT99927267 T AT 99927267T AT 99927267 T AT99927267 T AT 99927267T AT E413889 T1 ATE413889 T1 AT E413889T1
- Authority
- AT
- Austria
- Prior art keywords
- infant nutrition
- nutrition supplement
- insulin
- infant
- enriched infant
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Nutrition Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Pediatric Medicine (AREA)
- Mycology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Emergency Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Dairy Products (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9090998A | 1998-06-05 | 1998-06-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE413889T1 true ATE413889T1 (de) | 2008-11-15 |
Family
ID=22224914
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99927267T ATE413889T1 (de) | 1998-06-05 | 1999-06-03 | Insulin angereichertes säuglingsnährpräparat |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6365177B1 (de) |
| EP (1) | EP1083930B1 (de) |
| JP (2) | JP2002516880A (de) |
| AT (1) | ATE413889T1 (de) |
| AU (1) | AU762626B2 (de) |
| CA (1) | CA2334222C (de) |
| DE (1) | DE69939900D1 (de) |
| ES (1) | ES2320715T3 (de) |
| IL (1) | IL140089A (de) |
| WO (1) | WO1999062558A1 (de) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007520202A (ja) | 2003-06-20 | 2007-07-26 | ニュートリニア・リミテッド | 生物活性化合物の保護方法及びそれを含む組成物 |
| JP5693850B2 (ja) | 2007-02-06 | 2015-04-01 | リクスト・バイオテクノロジー,インコーポレイテッド | オキサビシクロヘプタンおよびオキサビシクロヘプテン、それらの製造および使用 |
| JP5694779B2 (ja) | 2008-01-09 | 2015-04-01 | サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | 極度に遅延した時間作用プロファイルを有する新規なインスリン誘導体 |
| US8227473B2 (en) | 2008-08-01 | 2012-07-24 | Lixte Biotechnology, Inc. | Oxabicycloheptanes and oxabicycloheptenes, their preparation and use |
| US8498729B2 (en) | 2008-08-29 | 2013-07-30 | Smp Logic Systems Llc | Manufacturing execution system for use in manufacturing baby formula |
| LT3228320T (lt) | 2008-10-17 | 2020-03-10 | Sanofi-Aventis Deutschland Gmbh | Insulino ir glp-1 agonisto derinys |
| EP3202394A1 (de) * | 2009-07-06 | 2017-08-09 | Sanofi-Aventis Deutschland GmbH | Wässrige insulinzubereitungen enthaltend methionin |
| PL2498802T3 (pl) | 2009-11-13 | 2015-06-30 | Sanofi Aventis Deutschland | Kompozycja farmaceutyczna zawierająca agonistę GLP-1, insulinę i metioninę |
| EP2498801B1 (de) | 2009-11-13 | 2018-01-24 | Sanofi-Aventis Deutschland GmbH | HARMAZEUTISCHE ZUSAMMENSETZUNG UMFASSEND desPro36Exendin-4(1-39)-Lys6-NH2 UND METHIONIN |
| SI2611458T1 (sl) | 2010-08-30 | 2017-01-31 | Sanofi-Aventis Deutschland Gmbh | Uporaba AVE0010 za izdelavo zdravila za zdravljenje sladkorne bolezni tipa 2 |
| US9821032B2 (en) | 2011-05-13 | 2017-11-21 | Sanofi-Aventis Deutschland Gmbh | Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin |
| HUE027989T2 (en) | 2011-08-29 | 2016-11-28 | Sanofi Aventis Deutschland | A pharmaceutical composition for use in glycemic control in patients with type 2 diabetes |
| AR087744A1 (es) | 2011-09-01 | 2014-04-16 | Sanofi Aventis Deutschland | Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa |
| RU2014145439A (ru) * | 2012-04-18 | 2016-06-10 | Нутриниа Лтд. | Увеличение темпов роста младенцев |
| US20150209412A1 (en) * | 2012-05-31 | 2015-07-30 | Nutrinia Ltd. | Insulin-containing infant formula |
| TWI641381B (zh) | 2013-02-04 | 2018-11-21 | 法商賽諾菲公司 | 胰島素類似物及/或胰島素衍生物之穩定化醫藥調配物 |
| EA201591931A1 (ru) | 2013-04-09 | 2016-05-31 | Ликсте Байотекнолоджи, Инк. | Композиции оксабициклогептанов и оксабициклогептенов |
| CA2932875A1 (en) | 2014-01-09 | 2015-07-16 | Sanofi | Stabilized glycerol free pharmaceutical formulations of insulin analogues and/or insulin derivatives |
| AU2015205620A1 (en) | 2014-01-09 | 2016-07-14 | Sanofi | Stabilized pharmaceutical formulations of insulin aspart |
| EP3091995B1 (de) | 2014-01-09 | 2024-03-20 | Sanofi | Stabilisierte pharmazeutische formulierungen von insulin aspart |
| CA2970200A1 (en) | 2014-12-12 | 2016-06-16 | Sanofi-Aventis Deutschland Gmbh | Insulin glargine/lixisenatide fixed ratio formulation |
| TWI748945B (zh) | 2015-03-13 | 2021-12-11 | 德商賽諾菲阿凡提斯德意志有限公司 | 第2型糖尿病病患治療 |
| TW201705975A (zh) | 2015-03-18 | 2017-02-16 | 賽諾菲阿凡提斯德意志有限公司 | 第2型糖尿病病患之治療 |
| US10617700B1 (en) | 2016-02-26 | 2020-04-14 | Michelle Ann Toothman | Vitamin supplement compositions with enhanced bioavailability |
| US10039805B1 (en) | 2016-02-26 | 2018-08-07 | Michelle Ann Toothman | Infant formulas having vitamin complexes with enhanced bioavailability |
| US11122833B1 (en) | 2016-02-26 | 2021-09-21 | Michelle Ann Toothman | Infant formulas having vitamin complexes with enhanced bioavailability |
| HUE062950T2 (hu) * | 2016-03-24 | 2023-12-28 | Elgan Pharma Ltd | Inzulin alkalmazása gyomorürülés elõsegítésére |
| ES2970913T3 (es) | 2016-12-08 | 2024-05-31 | Lixte Biotechnology Inc | Oxabicicloheptanos para modulación de la respuesta inmunitaria |
| ES2973984T3 (es) * | 2017-06-12 | 2024-06-25 | Elgan Pharma Ltd | Granulado multiparticulado que comprende insulina |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4944944A (en) * | 1987-11-19 | 1990-07-31 | Oklahoma Medical Research Foundation | Dietary compositions and methods using bile salt-activated lipase |
| JP3247206B2 (ja) * | 1993-06-11 | 2002-01-15 | 明治乳業株式会社 | ミルク組成物 |
| JP3238009B2 (ja) * | 1993-06-14 | 2001-12-10 | 雪印乳業株式会社 | 乳児用調製乳 |
| TW282398B (de) * | 1993-12-22 | 1996-08-01 | Bristol Myers Squibb Co | |
| JPH08214775A (ja) * | 1995-02-16 | 1996-08-27 | Meiji Milk Prod Co Ltd | アミノ酸組成を人乳に類似させた育児用乳製品 |
| JP3985035B2 (ja) * | 1995-09-14 | 2007-10-03 | 独立行政法人産業技術総合研究所 | (n−6)系ドコサペンタエン酸含有油脂ならびに該油脂の製造方法および用途 |
| JPH10146166A (ja) * | 1996-11-18 | 1998-06-02 | Nippon Shuzo Kumiai Chiyuuoukai | 生理活性組成物 |
-
1999
- 1999-06-03 AT AT99927267T patent/ATE413889T1/de not_active IP Right Cessation
- 1999-06-03 WO PCT/US1999/012594 patent/WO1999062558A1/en not_active Ceased
- 1999-06-03 ES ES99927267T patent/ES2320715T3/es not_active Expired - Lifetime
- 1999-06-03 CA CA2334222A patent/CA2334222C/en not_active Expired - Lifetime
- 1999-06-03 AU AU44212/99A patent/AU762626B2/en not_active Expired
- 1999-06-03 JP JP2000551812A patent/JP2002516880A/ja active Pending
- 1999-06-03 US US09/701,652 patent/US6365177B1/en not_active Expired - Lifetime
- 1999-06-03 DE DE69939900T patent/DE69939900D1/de not_active Expired - Lifetime
- 1999-06-03 EP EP99927267A patent/EP1083930B1/de not_active Expired - Lifetime
-
2000
- 2000-12-04 IL IL140089A patent/IL140089A/en not_active IP Right Cessation
-
2012
- 2012-01-06 JP JP2012001306A patent/JP5188631B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| AU762626B2 (en) | 2003-07-03 |
| EP1083930A1 (de) | 2001-03-21 |
| AU4421299A (en) | 1999-12-20 |
| EP1083930B1 (de) | 2008-11-12 |
| CA2334222C (en) | 2010-02-09 |
| EP1083930A4 (de) | 2005-01-12 |
| WO1999062558A1 (en) | 1999-12-09 |
| JP2002516880A (ja) | 2002-06-11 |
| JP5188631B2 (ja) | 2013-04-24 |
| CA2334222A1 (en) | 1999-12-09 |
| JP2012065675A (ja) | 2012-04-05 |
| ES2320715T3 (es) | 2009-05-27 |
| IL140089A (en) | 2006-06-11 |
| DE69939900D1 (de) | 2008-12-24 |
| US6365177B1 (en) | 2002-04-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE413889T1 (de) | Insulin angereichertes säuglingsnährpräparat | |
| HUP0301386A3 (en) | Supplement to be enterally administered for parenteral nutrition or partial enteral/oral nutrition of the critically ill. the chronically ill and people with malnutrition | |
| MXPA02010312A (es) | Modulos nutricionales. | |
| AU2002224848A1 (en) | Supplement to be enterally administered for parenteral nutrition or partial enteral/oral nutrition of the critically ill, the chronically ill and people with malnutrition | |
| ZA200110535B (en) | Gelled nutritional composition and process. | |
| ATE10707T1 (de) | Naehrloesung fuer die vollstaendige parenterale ernaehrung und fuer gesteigerte energieproduktion und verfahren zu deren herstellung. | |
| DE69806820D1 (de) | Kaloriereiche ernährungszusammensetzung | |
| MX9301300A (es) | Producto nutricional que contiene selenio y metodo para proporcionar selenio a tal producto. | |
| DK1478732T3 (da) | Selengærprodukt, fremgangsmåde til fremstilling af et selengærprodukt samt anvendelse af produktet til fremstilling af en födevare, et kosttilskud eller et lægemiddel | |
| ATE10156T1 (de) | An elementen reiche zusammensetzung. | |
| DE3268851D1 (en) | Mixture for human supply of selenium as a trace substance | |
| NZ240011A (en) | Oil-in-water emulsion nutritional composition: processes for production | |
| NO984859L (no) | Additiv for anvendelse i et energitilskudd, anvendelse av et proteinhydrolysat for fremstilling av energitilskudd inneholdende et slikt additiv | |
| DE69202227D1 (de) | Vorrichtung zur Herstellung von Sojabohnen-Quark und dessen Plazierung in Behältern. | |
| DK469488A (da) | Litiumholdigt ernaeringssupplement | |
| DE60032509D1 (de) | Chrom-histidin-komplexe als nahrungsmittelzusätze | |
| ATE308989T1 (de) | Zubereitung für oral zu verabreichende nahrungsergänzungs- und/oder arznelmittel in form von tabletten | |
| WO2001091766A3 (en) | Compositions for treating hand and wrist discomfort containing herbals and/or nutritional supplements and/or minerals and/or vitamins | |
| GB0511260D0 (en) | Improvements relating to infant care | |
| Stapleton | Infant feeding in the People's Republic of China | |
| CHENG et al. | Nutritional support in patients with gastrointestinal fistulas and biliary or pancreatic fistulas | |
| Craig | Farmyard beat | |
| ATE326148T1 (de) | Nahrungsergänzungsmittelpräparat | |
| DK63591D0 (da) | Triglycerid, naeringsmiddelkomposition omfattende et saadant triglycerid og anvendelse af naeringsmiddelkompositionen til ernaering | |
| DK63791A (da) | Triglycerider, naeringsmiddelkomposition omfattende saadanne triglycerider og anvendelse af naeringsmiddelkompositionen til ernaering |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |